Florida Smiles Dental Introduces Oral Surgeon Dr. Dominic
Florida Smiles Dental is happy to introduce their patients in Fort Lauderdale and Lighthouse Point to Dominic Morel, an excellent Oral Surgeon....
Stay updated with breaking news from Albert Einstein School. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Florida Smiles Dental is happy to introduce their patients in Fort Lauderdale and Lighthouse Point to Dominic Morel, an excellent Oral Surgeon....
Using the same approach they recently used to create effective vaccine candidates against COVID-19 and respiratory syncytial virus (RSV), scientists are tackling another virus: the tick-borne Crimean-Congo hemorrhagic fever (CCHF).
Within Health, an eating disorder treatment company, called on Facebook Tuesday to collaborate constructively in an effort to foster healing, amid whistleblower allegations that it knowingly led users to pro-eating disorder, pro-anorexia content. Within Health co-founder psychiatrist Dr. Wendy Oliver-Pyatt issued the following statement: “I was disturbed and disheartened by the whistleblower’s testimony that Facebook
MedRhythms, in collaboration with Boston University, is launching a clinical trial of its pipeline asset MR-005 in Parkinson’s disease (PD). In addition, the company is expanding its pipeline into aging with the development of its Aging Scientific Advisory Board (SAB). This follows MedRhythms’ announcement of the advancement of its pipeline into PD and multiple sclerosis (MS) in 2020 with the initiation of clinical trials and the development of MS and PD SABs. MedRhythms, headquartered in Portland, Me, is a digital therapeutics company that builds direct stimulation solutions that use cl...
MedRhythms Launches Clinical Trial of Digital Therapeutic in Parkinson's Disease and Expands Pipeline to Aging News provided by Share this article Share this article PORTLAND, Maine, April 13, 2021 /PRNewswire/ -- MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, today announced the initiation of a multi-site clinical trial, in collaboration with Boston University and one of the world's leading hospitals, of its pipeline asset MR-005 in Parkinson's ...